HOME >> MEDICINE >> NEWS
CHARM* Programme demonstrates clear benefits of Atacand in the treatment of heart failure

(Vienna, 31st August 2003) Data presented today at the European Society of Cardiology (ESC) annual meeting demonstrated Atacand (candesartan cilexetil) to reduce both cardiovascular deaths as well as hospital admissions for heart failure, across a broad spectrum of patients with chronic heart failure.

Importantly, Atacand is the first Angiotensin Receptor Blocker (ARB) to increase survival in chronic heart failure patients with left ventricular dysfunction, whether or not they are taking an ACE-inhibitor.

CHARM co-chairman, Professor Karl Swedberg, Gteborg University and Sahlgrenska University Hospital/stra, Gteborg, Sweden introduced the rationale behind the CHARM Programme: "While the incidence of most cardiovascular disease is stabilising, chronic heart failure remains a serious and costly condition with patients being symptomatic and at risk of early death. Although major advances in the treatment of heart failure have occurred in the last decade or so, there is still a real need for additional, effective therapies and this requirement led us to devise the CHARM Programme in order to evaluate the clinical benefits of candesartan in the treatment of this debilitating and distressing condition".

The CHARM Programme, which recruited 7,601 patients, is the largest ever trial programme conducted in heart failure with an AT1-receptor blocker. Patients with classic symptomatic chronic heart failure depressed left ventricular (LV) systolic function (Left Ventricular Ejection Fraction (LVEF) < 40%), were randomised into one of two studies either an ACE-inhibitor intolerant population (CHARM-Alternative), or the population treated with ACE-inhibitors (CHARM-Added). In addition, patients with preserved LV systolic function (LVEF> 40%) were also randomised into a third study (CHARM-Preserved). All patients received either Atacand (candesartan cilexetil) or placebo.

CHARM-Alternative

In patients who were not taking ACE-in
'"/>

Contact: Mark Chamberlain
mark.chamberlain@ketchum.com
44-20-7611-3649
Ketchum
2-Sep-2003


Page: 1 2 3 4

Related medicine news :

1. Further Evidence On The Effect Of The UK Cervical Screening Programme
2. New study in Nature demonstrates protection against cell death during heart attack
3. ZYVOX(R) demonstrates high success rate for patients who develop MRSA surgical site infections
4. New study demonstrates co-administration
5. New data demonstrates that Benicar(R) and Benicar HCT (TM) achieve JNC 7 blood pressure goals
6. New study demonstrates significant and sustained improvements in BPH symptoms with AVODART ™
7. New Canadian study demonstrates clear survival benefit of treatment in trials and at large centres
8. New study demonstrates key benefits of RISPERDAL(R) CONSTA(R) in young adults with schizophrenia
9. UF smart home demonstrates concept of automated elderly help and care
10. Study demonstrates improved survival in women with metastatic breast cancer
11. Residential addiction treatment demonstrates economic benefits

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: